Continuous Glucose Monitoring (CGM) Market - Forecasts fom 2025 to 2030

The Continuous Glucose Monitoring (CGM) Market is expected to grow from USD 8.984 billion in 2025 to USD 17.119 billion in 2030, at a CAGR of 13.76%.

The global continuous glucose monitoring (CGM) market is experiencing robust growth, driven by the escalating prevalence of diabetes worldwide. CGM systems, utilizing subcutaneous sensors and wireless transmitters to track blood glucose levels in real time, provide critical data for managing diabetes and tailoring patient treatments. The market is propelled by increasing diabetes rates, technological advancements, and supportive government initiatives, positioning CGM as a vital tool in diabetes care through 2030.

Market Growth Drivers

Growing Prevalence of Diabetes

The rising incidence of diabetes, fueled by sedentary lifestyles, insulin resistance, and genetic factors, is a primary driver. CGM devices enable patients and healthcare providers to monitor glucose levels closely, facilitating timely interventions. Government programs and subsidies enhance access to CGM devices, particularly for type 1 diabetes patients, boosting adoption. The projected increase in global diabetes cases-expected to reach 643 million by 2030-underscores the growing demand for CGM solutions, especially in low- and middle-income countries where prevalence is rising rapidly.

Recent Developments

Significant investments by companies are accelerating CGM commercialization and innovation. Product launches, such as advanced CGM devices with smaller, more reliable sensors, are enhancing user convenience and accuracy. Innovations like networked and automated monitoring systems are on the horizon, promising seamless integration with smart devices. Long-lasting sensors, extending usability beyond traditional short-term systems, are gaining traction, further driving market growth through improved patient compliance and reduced replacement costs.

Market Segment Analysis

The diabetes patient segment dominates the CGM market, driven by the increasing prevalence of diabetes and demand for monitoring devices with favorable reimbursement policies. Type 1 and type 2 diabetes patients benefit from CGM's ability to provide continuous data, reducing complications like blindness, kidney failure, and cardiovascular issues. The introduction of cutting-edge technologies, such as needle-free biosensors and app-integrated devices, enhances market appeal, particularly in regions with high diabetes burdens.

Regional Insights

North America leads the CGM market, fueled by a growing geriatric population, high diabetes prevalence, and substantial investments in advanced glucose monitoring solutions. The U.S. is a key contributor, with companies allocating significant funds to develop innovative CGM platforms. The Asia Pacific region is poised for rapid growth, driven by rising diabetes rates and improving healthcare infrastructure in countries like China and India. Europe, the Middle East, Africa, and South America also contribute, with regional efforts to address diabetes care needs.

Market Outlook

The CGM market is set for significant expansion through 2030, driven by diabetes prevalence, technological innovations, and government support. North America's dominance and Asia Pacific's rapid growth highlight key opportunities. Challenges, such as high device costs, are being mitigated through subsidies and advancements in cost-effective technologies. The market's trajectory underscores CGM's critical role in transforming diabetes management globally, with ongoing R&D ensuring sustained momentum.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2020 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

USA CGM Market Segmentation:

By Application

• Diabetes Patients
• Critical Patients

By End-User Industry

• Hospitals
• Diagnostic Centers & Clinics
• Home Care
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others